ConductScience.org, home

Paper62609

Intracavitary bleomycin in the management of malignant effusions.

Paladine W and 5 others. Cancer, 1976. Cited by 166 papers, by iCite.

Cite this record

ConductScience Library. Intracavitary bleomycin in the management of malignant effusions. Papers, record 62609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/62609

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intracavitary bleomycin in the management of malignant effusions.
PubMed
Journal
Cancer
PubMed
Year
1976
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
166
iCite
Relative citation ratio, by iCite
8.65
iCite
Revised in PubMed
2019-06-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Paladine WW
2Cunningham TJT J
3Sponzo RR
4Donavan MM
5Olson KK
6Horton JJ

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AscitesMajor topic
BleomycinMajor topic
Pleural EffusionMajor topic
ThoraxMajor topic
Drainage
Humans
Injections
Neoplasms

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.

PMIDTitleJournalYearIn PapersSource
40343001
Intrapleural administration with traditional Chinese medicine injections (Sophorae flavescentis preparations) in controlling malignant pleural effusion: a clustered systematic review and meta-analysis.
Front Pharmacol2025https://conductscience.org/library/papers/40343001PubMed
34414103Intrapleural Administration With Rh-Endostatin and Chemical Irritants in the Control of Malignant Pleural Effusion: A Systematic Review and Meta-Analysis.Front Oncol2021https://conductscience.org/library/papers/34414103PubMed
34405047Time course of histopathological changes after bleomycin sclerotherapy in rabbit gallbladders as a model for simple hepatic cysts.Biomed Rep2021https://conductscience.org/library/papers/34405047PubMed
34182522Systemic Inflammatory Response to Different Sclerosing Agents as a Predictor of Pleurodesis Outcome.In Vivo2021https://conductscience.org/library/papers/34182522PubMed
30526440Efficacy and safety profile of autologous blood versus talc pleurodesis for malignant pleural effusion: a randomized controlled trial.Ther Adv Respir Dis2018https://conductscience.org/library/papers/30526440PubMed
24124397Epithelial cell-adhesion molecule-directed trifunctional antibody immunotherapy for symptom management of advanced ovarian cancer.Clin Pharmacol2013https://conductscience.org/library/papers/24124397PubMed
22927770Emerging treatment options for management of malignant ascites in patients with ovarian cancer.Int J Womens Health2012https://conductscience.org/library/papers/22927770PubMed
20396568Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion.Cancer Res Treat2004https://conductscience.org/library/papers/20396568PubMed
10360655Multi-institutional randomized clinical study on the comparative effects of intracavital chemotherapy alone versus immunotherapy alone versus immunochemotherapy for malignant effusion.Br J Cancer1999https://conductscience.org/library/papers/10360655PubMed
9463789Management of malignant pleural effusions.Drugs1998https://conductscience.org/library/papers/9463789PubMed
9292710Immunocytochemical detection of P-glycoprotein in the management of malignant effusions.J Cancer Res Clin Oncol1997https://conductscience.org/library/papers/9292710PubMed
8118118The intrapleural administration of recombinant interleukin-2 (rIL-2) to patients with malignant pleural effusion: clinical trials.Surg Today1993https://conductscience.org/library/papers/8118118PubMed
7697307Intracavitary therapy of neoplastic effusions with cytokines: comparison among interferon alpha, beta and interleukin-2.Support Care Cancer1995https://conductscience.org/library/papers/7697307PubMed
7692617Chemical pleurodesis in malignant pleural effusions: a randomised prospective study of mepacrine versus bleomycin.Thorax1993https://conductscience.org/library/papers/7692617PubMed
7539702Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions.Support Care Cancer1995https://conductscience.org/library/papers/7539702PubMed
7512285Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions.Thorax1994https://conductscience.org/library/papers/7512285PubMed
6162444[Animal experiments for intratumoral chemotherapy with bleomycin (author's transl)].Arch Otorhinolaryngol1980https://conductscience.org/library/papers/6162444PubMed
6157449Pleural aspiration and biopsy.Br Med J1980https://conductscience.org/library/papers/6157449PubMed
4035618Further experience of Corynebacterium parvum in malignant pleural effusion.Thorax1985https://conductscience.org/library/papers/4035618PubMed
3887760Intracavitary chemotherapy for malignant disease confined to body cavities.West J Med1985https://conductscience.org/library/papers/3887760PubMed

See all 28 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/62609

GET https://conductscience.org/api/papers/v1/62609/cited_by?page=2